| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cardiff Oncology, Inc. | Interim CEO, Director | Stock Options | 368,766 | 17 Feb 2026 | Direct | ||
| CytomX Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 38,000 | 11 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRDF | Cardiff Oncology, Inc. | 17 Feb 2026 | 1 | $0 | 4 | Interim CEO, Director | 18 Feb 2026, 16:01 |
| CRDF | Cardiff Oncology, Inc. | 26 Jun 2025 | 1 | $0 | 4 | Director | 30 Jun 2025, 09:38 |
| CTMX | CytomX Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 16:18 |
| CRDF | Cardiff Oncology, Inc. | 27 Jun 2024 | 1 | $0 | 4 | Director | 01 Jul 2024, 16:09 |
| CTMX | CytomX Therapeutics, Inc. | 15 May 2024 | 1 | $0 | 4 | Director | 17 May 2024, 17:34 |
| CRDF | Cardiff Oncology, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 20 Jun 2023, 17:03 |
| CTMX | CytomX Therapeutics, Inc. | 14 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 17:52 |
| CTMX | CytomX Therapeutics, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:07 |
| CRDF | Cardiff Oncology, Inc. | 09 Mar 2022 | 1 | $0 | 4 | Director | 10 Mar 2022, 17:42 |
| CTMX | CytomX Therapeutics, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 18:48 |
| CRDF | Cardiff Oncology, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 16:12 |
| CRDF | Cardiff Oncology, Inc. | 10 Jun 2021 | 0 | $0 | 3 | Director | 14 Jun 2021, 16:01 |